• October 11, 2022  

    Demystifying Cancer Biomarkers: Webinar Recap

    Sarah Stanley

    If you have just been diagnosed with cancer, or are facing recurrence, progression, or a change in treatment, you may feel bombarded with new information and advice. At some point, a clinician or even a well-meaning friend may urge you to have “biomarker testing” done. This phrase can be especially confusing when dealing with the stress of trying to understand a new diagnosis, a… Read more »

  • August 23, 2022  

    Using AI and Drug Testing to Design Personalized Cancer Drug Combos

    With: Noah Berlow, PhDDiana Azzam, PhD

    Advanced cancer treatment often involves combining multiple drugs. But with a huge number of possible combinations, it is difficult to know which mix might work best for each patient. Here, our Curious Dr. George asks two leaders to describe how the company First Ascent Biomedical is addressing this challenge. Curious Dr. George: The U.S. Food and Drug Administration (FDA) has approved many thousands of… Read more »

  • March 22, 2022  

    Immunotherapy Approvals Signal a Need for Molecular Testing in Endometrial Cancer Bookmark

    George Lundberg, MD

    Molecular testing often guides choices of immunotherapy, as illustrated in this OncLive story about endometrial cancer.

    .

  • March 22, 2022  

    Immunotherapy to Treat Cancer Bookmark

    George Lundberg, MD

    Immunotherapy uses biological substances, such as your own immune system, to attack cancer cells. Learn more about immunotherapy from the National Cancer Institute.

    .

  • March 22, 2022  

    Biomarker Testing for Cancer Treatment Bookmark

    George Lundberg, MD

    Each person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.

    .

  • March 22, 2022  

    Targeted Therapy to Treat Cancer Bookmark

    George Lundberg, MD

    “Targeted therapy is a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. It is the foundation of precision medicine.” —Prepared by the National Cancer Institute, this website provides an excellent overview of targeted therapy for treating cancer.

    .

  • March 8, 2022  

    Using Protein Analysis to Understand Esophageal Cancer Bookmark

    George Lundberg, MD

    In order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.

    .

    .

  • March 3, 2022  

    More Information from Less Tissue: Strata Oncology Excels

    With: Scott A. Tomlins, MD, PhDLaura E. Lamb, PhD

    For a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its weakest link. In the “brain-to-brain” concept of… Read more »

  • June 12, 2021  

    Improving Access to Genetic Testing and Counseling Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about eReach, a study investigating whether telehealth can provide improved access to genetic testing for people at risk for cancer.

    .

  • June 12, 2021  

    Decoding the Differences between At-Home and Medical Genetic Testing Bookmark

    Lola Rahib, PhD

    Article from Let’s Win! Pancreatic Cancer: Learn about how the cost, access, accuracy, privacy and other aspects of at-home genetic testing compare to medical genetic testing with a specialist. 

    .